Splenic hamartoma
Updates to Article Attributes
Splenic hamartomas are very rare lesions commonly found incidentally on imaging. They are most often solitary but may be present as multiple nodules in patients with tuberous sclerosis or Wiskott-Aldrich syndrome.
Terminology
The only recently described entity sclerosing angiomatoid nodular transformation (SANT) of the spleen, a non-neoplastic vascular entity described and named in 2004 5 may be a fibrosing variant of splenic hamartoma 6.
Epidemiology
Splenic hamartomas are very rare, with only 3 described in a series of 200000 splenectomies.
Clinical presentation
Hamartomas are normally an incidental finding at imaging, surgery or autopsy. They can occur in any age group. Symptoms occur from mass effect if they grow large.
Pathology
Hamartomas are solitary or multiple, round, well-circumscribed, unencapsulated bulging nodules compressing the adjacent normal splenic parenchyma and compounded by a mixture of normal splenic structures such as white and red pulp. Focal fibrosis and cystic areas can be seen.
The pathological differential diagnosis includes haemangioma, Littoral cell angioma, lymphangioma, haemangioendothelioma, sclerosing angiomatoid nodular transformation (see terminology), angiosarcoma. A definite diagnosis can be difficult due to the overlap of features, however, positivity of CD8 is a key feature that differentiates hamartoma from other vascular lesions of the spleen.
Radiographic features
As hamartomas represent a focal excessive overgrowth of splenic parenchyma in a disorganised way, they tend to have similar echogenicity, attenuation, and signal intensity to the background normal parenchyma 7.
Ultrasound
Most splenic hamartomas are hypoechoic solid masses, but can be heterogeneous due to haemorrhage or cystic changes 7. They are hypervascular in both colour Doppler ultrasound and post contrast administration.
CT
On computed tomography, hamartomas appear as isodense or hypodense solid masses and demonstrate heterogeneous contrast enhancement relative to the adjacent normal parenchyma.
MRI
MRI is the preferred imaging technique for its distinction from haemangiomas, showing:
- T1: most lesions are isointense
- T2: most lesions are heterogeneously hyperintense
-
T1 C+ (Gd):
- it is typical to show vivid enhancement on immediate postcontrast-enhanced images (key features in the differentiation between hamartomas and hemangiomas)
- on delayed postcontrast images, hamartoma enhances in a relatively uniform and intense fashion +/- with central hypovascular areas
Differential diagnosis
Possible differential considerations include
- splenic haemangioma
-
splenic
lymphangiomalymphangioma- lobulated multiseptated cystic mass without solid enhancing components
- may have wall/septa linear calcifications
-</ul><h4>Differential diagnosis</h4><ul>-<li><a href="/articles/splenic-haemangioma">haemangioma</a></li>- +</ul><h4>Differential diagnosis</h4><p>Possible differential considerations include</p><ul>
- +<li><a title="splenic haemangioma" href="/articles/splenic-haemangioma">splenic haemangioma</a></li>
-<a href="/articles/splenic-lymphangioma">lymphangioma</a><ul>- +<a title="splenic lymphangioma" href="/articles/splenic-lymphangioma">splenic </a><a href="/articles/splenic-lymphangioma">l</a><a title="splenic lymphangioma" href="/articles/splenic-lymphangioma">ymphangioma</a><ul>